Xtant Q1 revenue drops 6.7%, net loss hits $2.8M: 4 key notes

Written by Laura Dyrda | May 16, 2019 | Print  |

Xtant Medical reported 2019 revenue was down slightly during the first quarter, but it did reduce year over year net loss and generated positive cash flow from operations.


Four things to know:

1. Revenue dropped 6.7 percent from $17.9 million to $16.7 million in the first quarter due to lower sales in the spinal hardware product line.

2. Xtant's gross margin in the first quarter was 64.6 percent, down from 68.2 percent over the same time period last year. The decrease was due to inventory reserves and manufacturing overhead absorption.

3. During the first quarter, operating expenses dropped from $13.9 million in 2018 to $11.5 million for 2019 as a result of lower sales commissions and travel expenses.

4. Xtant Medical's first quarter net loss was $2.8 million, down from $5.3 million over the same period last year.

More articles on orthopedic devices:
12 orthopedic, spine device company key notes
PE firm acquires majority stake in CrossRoads Extremity Systems – 4 insights
Medtronic reaches 2nd ASC with newest Mazor edition

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers